EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A nomogram with Ki-67 in the prediction of postoperative recurrence and death for glioma

Fengfeng Li, Dongyuan Wang, Nana Wang, Linlin Wu, Bo Yu

Scientific Reports · 02.09.2024 · 14 (1)

DOI: 10.1038/s41598-024-71275-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 02.09.2024. Verfasst von Fengfeng Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Department, Tengzhou Central People's Hospital Affiliated to Xuzhou Medical University, Tengzhou, China. Hauptthemen laut MEDLINE: Glioma, Ki-67 Antigen, Nomograms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Xuzhou Medical University Affiliated Hospital Development Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examined to evaluate the predictive value of a nomogram with Ki-67 in overall and disease-free survival in glioma patients, a total of 76 patients diagnosed with glioma by pathology in Tengzhou Central People's Hospital were enrolled. The baseline data and follow ups were retrospectively collected from medical records. The associations between Ki-67 and survival status were examined using log-rank test, univariate and multivariate Cox proportional hazard regression models. Calibrations were performed to validate the established nomograms. Ki-67 negative group showed of a longer OS survival time and a longer PFS survival time with log-rank test (x2 = 16.101, P < 0.001 and x2 = 16.961, P < 0.001). Age older than 50 years (HR = 2.074, 95% CI 1.097-3.923), abnormal treatment (HR = 2.932, 95% CI 1.343-6.403) and Ki-67 positive (HR = 2.722, 95% CI 1.097-6.755) were the independent predictive factors of death. High grade pathology (HR = 2.453, 95% CI 1.010-5.956) and Ki-67 positive (HR = 2.200, 95% CI 1.043-4.639) were the independent predictive factors of recurrence. The C-index for the nomogram of OS and PFS were 0.745 and 0.723, respectively. The calibration results showed that the nomogram could predict the overall and disease-free 1-year survival of glioma patients. In conclusion, the nomograms with Ki-67 as independent risk factor for OS and PFS could provide clinical consultation in the treatment and follow-up of malignant glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaKi-67 AntigenNomogramsNeoplasm Recurrence, LocalBrain NeoplasmsHumansFemaleMaleMiddle AgedAdultRetrospective StudiesAgedPrognosisDisease-Free SurvivalProportional Hazards Models

Stichwörter der Autor:innen

DeathGliomaKi-67NomogramRecurrence

Substanzen

Ki-67 Antigen

Autor:innen und Institutionen

  • Neurosurgery Department, Tengzhou Central People's Hospital Affiliated to Xuzhou Medical University, Tengzhou, China.
  • Oncology Department, Tengzhou Central People's Hospital Affiliated to Xuzhou Medical University, Tengzhou, 277500, China. Docbaoqiang3524@outlook.com.
  • Intensive Care Unit, Tengzhou Central People's Hospital Affiliated to Xuzhou Medical University, Tengzhou, 277500, China. Docqiang7471@outlook.com.

Förderung

  • Xuzhou Medical University Affiliated Hospital Development Fund Project

Zitieren

APA

Li, F., Wang, D., Wang, N., Wu, L., & Yu, B. (2024). A nomogram with Ki-67 in the prediction of postoperative recurrence and death for glioma. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-71275-9

Vancouver

Li F, Wang D, Wang N, Wu L, Yu B. A nomogram with Ki-67 in the prediction of postoperative recurrence and death for glioma. Scientific Reports. 2024;14(1). doi:10.1038/s41598-024-71275-9

BibTeX
@article{Li2024,
  author = {Li, Fengfeng and Wang, Dongyuan and Wang, Nana and Wu, Linlin and Yu, Bo},
  title = {A nomogram with Ki-67 in the prediction of postoperative recurrence and death for glioma},
  journal = {Scientific Reports},
  year = {2024},
  volume = {14},
  number = {1},
  doi = {10.1038/s41598-024-71275-9}
}
Kostenlos starten →